Data Integrity
Securing the integrity of your electronic data and records is critical for safeguarding patient safety
Data Integrity Services
Data Integrity Risk Assessments
We take a consistent, standardized approach when performing data integrity risk assessments to fully encompass the requirements documented by the US FDA, EMA, MHRA,...
Read MoreData Integrity Risk Assessments
We take a consistent, standardized approach when performing data integrity risk assessments to fully encompass the requirements documented by the US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA.
Read LessPolicies & Procedures Framework
We will ensure that data integrity is “built-in” from the start. Our data integrity consultants can have a QMS framework ready in a few weeks.
Policies & Procedures Framework
We will ensure that data integrity is “built-in” from the start. Our data integrity consultants can have a QMS framework ready in a few weeks.
Read LessEssential Training for Your Organization
Our catalog of Data Integrity training courses can be provided ‘as is’ or tailored to include examples from your daily operations.
Essential Training for Your Organization
Our catalog of Data Integrity training courses can be provided ‘as is’ or tailored to include examples from your daily operations.
Read LessData Governance Programs
We guide you through the steps of implementing a Data Integrity Program to monitor data integrity practices and ensure they continue to mature.
Data Governance Programs
We guide you through the steps of implementing a Data Integrity Program to monitor data integrity practices and ensure they continue to mature.
Read LessStandard Compliant Documentation, Tailored for You
We tailor our standard suite of documents, built from US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA data integrity guidelines, to fit your...
Read MoreStandard Compliant Documentation, Tailored for You
We tailor our standard suite of documents, built from US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA data integrity guidelines, to fit your organization.
Read LessALCOA Principles Applied
We follow a consistent, standardized approach when performing data integrity risk assessments to fully encompass ALCOA principles and requirements documented by the US FDA,...
Read MoreALCOA Principles Applied
We follow a consistent, standardized approach when performing data integrity risk assessments to fully encompass ALCOA principles and requirements documented by the US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA.
Read LessData Integrity Risk Assessments
Everyone has heard the acronym "ALCOA", but our experts have experience assessing real-life situations vs. the principles of ALCOA to identify data integrity risks.
The purpose of a data integrity risk assessment is to provide you with the information you need to mitigate data integrity risks before your organization has a serious data integrity issue.
ProPharma’s data integrity consultants follow a consistent, standardized approach when performing data integrity risk assessments to fully encompass the requirements documented by the US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA.


Here are the steps we take:
- Meet to discuss your industry, products, and markets to determine the appropriate regulatory guidelines and any specific areas of concern, e.g., from CAPAs or past audits.
- Tailor our standard assessment checklists to place the emphasis on the areas of highest risk.
- Conduct the data integrity risk assessment – policies and procedures first, then specific systems and processes. The assessments include demonstrations of system functionality, review of policies and procedures, interviews with subject matter experts, and review of validation documentation.
- Provide a Data Integrity Risk Assessment report identifying the areas of data integrity risk. Each risk is categorized as ‘critical’, ‘major’, or ‘minor’ to aid in prioritization of remediation activities.
- Provide a Report of Recommended Actions for closure of each data integrity risk.
- Facilitate follow-up meetings to ensure that the risks and recommendations are understood.
Data Integrity Framework of Policies & Procedures
A robust suite of Policies, Procedures, Work Instructions, and Templates provides the framework to ensure that data integrity is “built-in” from the start. ProPharma’s experienced data integrity consultants can have a QMS framework ready in a few weeks.
Here are the steps we take:
- Meet to discuss what makes your organization unique, e.g.,
- Industry-specific regulations, e.g., AOPO, CAP, COLA
- Organization structure, roles, and responsibilities
- Computer systems and tools already in use
- Tailor ProPharma’s standard suite of documents, built from US FDA, EMA, MHRA, WHO, PIC/S, ISPE, and PDA data integrity guidelines, to fit your organization.
- Solicit feedback on the preliminary suite of documents and make adaptations before finalizing the Policies, Procedures, Work Instructions, and Templates.
- Develop a Quality Manual to summarize the Policy and Procedure framework and provide an overview for employees, auditors, and inspectors.


Data Integrity Training
Delivering the right level of training at the right time is essential for embedding the principles of data integrity into company culture.
ProPharma has a catalog of Data Integrity training courses that can be provided ‘as is’ or tailored to include examples from your daily operations.
- Short training courses on Data Integrity Principles, suitable for Data Integrity program implementation and annual refresher training
- Longer training courses on advanced Data Integrity topics such as:
- ALCOA in Practice
- Data Integrity Roles & Responsibilities
- Data Governance Models
- Digital Signatures
- Computer System Validation
Data Governance Programs
A Data Governance program is more than simply determining who ‘owns’ the data. It’s a program to monitor data integrity practices in real-time and ensure that they continue to mature.
ProPharma’s data integrity consultants will guide you through the steps of implementing a Data Integrity Program that includes:
- A structured program with defined roles and responsibilities for both leaders and subject matter experts
- Processes for real-time monitoring of data integrity health through ongoing review of internal audit findings, metrics, and incident reports
- Processes for prioritizing and initiating course corrections to ensure that issues are not repeated, and data integrity health metrics continue to improve
- Standard process for building a roadmap to improve the organization’s Data Integrity program through strategic investments and targeted process improvements


Data Integrity Training & Resources
Access essential training and resources for computer system validation, compliance, and data integrity at Validation Center, ProPharma knowledge center and resource.
Attend free webinars, enroll in online and in-person classes in the US and Europe, and download valuable templates and standard operating procedures. Validation Center offers everything you need for CSV and software quality assurance.
Meet our Data Integrity Experts
-
Deb Bartel
Vice President of Quality Assurance
-
Bob Verhoeff
Associate Director, Computer System Validation & Data Integrity
-
Rodrigo Perez
Associate Director, Computer System Validation & Data Integrity
Deb Bartel
Bob Verhoeff
Rodrigo Perez
News & Insights

October 2, 2025
Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...
Discover how ProPharma's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

September 30, 2025
Tips for Preparing Successful FDA 510(k) Submissions
Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

July 8, 2025
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

October 6, 2025
Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...
When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, ProPharma stepped in —...
-chcecklist-complete-guide-fda-510k-submissions-ppg.png?width=320&height=185&name=510(k)-chcecklist-complete-guide-fda-510k-submissions-ppg.png)
September 30, 2025
Your Complete FDA 510(k) Premarket Notification Checklist
Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

October 16, 2025
AI in Medical Information: Who Holds the Responsibility?
In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

September 25, 2025
Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy
Medical Information (MI) and Pharmacovigilance (PV) work together to protect public health by identifying and evaluating emerging safety signals. Watch our in-depth webinar, where our experts explore...
News & Insights

October 6, 2025
Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...
When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, ProPharma stepped in —...

September 25, 2025
Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy
Medical Information (MI) and Pharmacovigilance (PV) work together to protect public health by identifying and evaluating emerging safety signals. Watch our in-depth webinar, where our experts explore...
Customized Strategy. Globally Scaled Solutions
ProPharma helps clients mitigate data integrity risks and ensure compliance with FDA, EMA, MHRA, and other agency standards.